Insider · CIK 0002127840
Robert Edward Walker
Files at NVAX (NOVAVAX INC). First filing -, latest -.
Robert Edward Walker files SEC Form 4 as officer at NVAX (NOVAVAX INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Edward Walker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | NVAX NOVAVAX INC | AGrant or award Stock Option (Right to Buy)derivative | +99,500 | $0.00 | $0 | 99,500 | Apr 16, 2026 |
| Apr 14, 2026 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +66,000 | $0.00 | $0 | 6,600 | Apr 16, 2026 |
Questions about Robert Edward Walker
Answered from the filings on this page, as of the latest one.
Is Robert Edward Walker buying or selling?
Robert Edward Walker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Edward Walker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Edward Walker has 0.
Where does Robert Edward Walker file Form 4?
Robert Edward Walker has filed Form 4 at NVAX (NOVAVAX INC) as EVP, R&D. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.